These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24009316)

  • 21. Health technology assessment in Canada: 20 years strong?
    Menon D; Stafinski T
    Value Health; 2009 Jun; 12 Suppl 2():S14-9. PubMed ID: 19523180
    [No Abstract]   [Full Text] [Related]  

  • 22. What is the National Horizon Scanning Centre (NHSC)?
    Nurs Times; 1999 Aug 18-24; 95(33):15. PubMed ID: 10614401
    [No Abstract]   [Full Text] [Related]  

  • 23. New Canadian priority: cohesive tech assessment.
    Souhrada L
    Hospitals; 1989 Sep; 63(17):44. PubMed ID: 2767633
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Care to compare?
    Aston G
    Hosp Health Netw; 2008 Dec; 82(12):38-41, 1. PubMed ID: 19209502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UK Health Technology Assessment (HTA) Programme.
    J Med Screen; 2005; 12(4):207-8. PubMed ID: 16417701
    [No Abstract]   [Full Text] [Related]  

  • 27. Healthcare technology co-operatives: Innovative about innovation.
    Heron NM; Tindale WB
    J Med Eng Technol; 2014; 39(7):378-81. PubMed ID: 26453035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment and regulation of health care technology. The Dutch experience.
    Boer A
    Int J Technol Assess Health Care; 1999; 15(4):638-48. PubMed ID: 10645105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health technology assessment in the United Kingdom.
    Drummond M; Banta D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():178-81. PubMed ID: 19527538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ECRI vice president sees need for transparency, better information.
    Montagnolo AJ
    Biomed Instrum Technol; 2012; 46(6):446-9. PubMed ID: 23171186
    [No Abstract]   [Full Text] [Related]  

  • 31. NICE and new: appraising innovation.
    Ferner RE; Hughes DA; Aronson JK
    BMJ; 2010 Jan; 340():b5493. PubMed ID: 20051468
    [No Abstract]   [Full Text] [Related]  

  • 32. Health technology assessment: reflections from the Antipodes.
    Bulfone L; Younie S; Carter R
    Value Health; 2009 Jun; 12 Suppl 2():S28-38. PubMed ID: 19523182
    [No Abstract]   [Full Text] [Related]  

  • 33. Health technology assessments and innovation.
    Tucker J; Boone K; Fedak P
    Nat Biotechnol; 2013 Nov; 31(11):970-1. PubMed ID: 24213766
    [No Abstract]   [Full Text] [Related]  

  • 34. Making decisions on technology availability in the British National Health Service--why we need reliable models.
    Akehurst RL
    Value Health; 2003; 6(1):3-5. PubMed ID: 12535232
    [No Abstract]   [Full Text] [Related]  

  • 35. The National Institute for Health Research Health Technology Assessment Programme. Bulletin for the journal of medical screening (updated May 2007).
    J Med Screen; 2007; 14(2):107-8. PubMed ID: 17626712
    [No Abstract]   [Full Text] [Related]  

  • 36. Consumers are helping to prioritise research.
    Royle J; Oliver S
    BMJ; 2001 Jul; 323(7303):48-9. PubMed ID: 11464824
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.
    Henry DA; Hill SR; Harris A
    JAMA; 2005 Nov; 294(20):2630-2. PubMed ID: 16304078
    [No Abstract]   [Full Text] [Related]  

  • 38. National Institute for Health and Clinical Excellence: the Medical Technologies Evaluation Programme.
    J Med Eng Technol; 2011 Jul; 35(5):283-4. PubMed ID: 21635177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
    Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
    Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.